Pharmafusion CEO To Be Featured Presenter at CBI Gross-to-Net Summit
EAST NORRITON, Pa., Nov. 13, 2018
EAST NORRITON, Pa., Nov. 13, 2018 /PRNewswire-PRWeb/ -- Pharmafusion LLC announced today that company founder and Chief Executive Officer Jonathan Retano will be a featured presenter at the upcoming CBI Gross-to-Net (GTN) Summit in Philadelphia on Thursday, November 15. In addition, the company will host a hospitality suite on Friday, November 16, where conference attendees will have the opportunity to "test drive" the company's Pharmafusion360° platform and discuss how the platform could positively impact their company's business.
"Pharmafusion offers our clients an all-inclusive, cloud-based business analytics platform designed specifically for the pharmaceutical and biotech industries," says Retano. "Essentially a one-stop-shop for fresh data, we deliver customizable reports and dashboards rapidly from diverse data sources to support commercialization efforts. Having all the key components and supporting data in one platform allows users to create a more holistic view of GTN faster."
For his November 15 presentation, Retano will host what the conference has tabbed a "Solutions Summit" where attendees will engage in a small group setting for highly interactive system demonstrations of the Pharmafusion360° platform. Designed to provide insight from nearly 50 subject areas from a multidimensional enterprise data warehouse built explicitly for pharma, end-users of the platform have the ability to customize data sets received via web and tablet enabled reports. This customization allows users to minimize clutter and review only the content that is most essential for their business analytics needs. Pharmafusion leadership likens their approach to the technology as a pharmaceuticals and life-sciences version of "Smart TV" where Pharmafusion360° cost-effectively provides various informative "channels" to clients in an easy to use and visually appealing way.
During the November 16 hospitality suite session, Retano will be available to interact in more one-on-one conversations with attendees to further demonstrate how the Pharmafusion360° platform can benefit potential clients.
"We are looking forward to CBI GTN and having the ability to introduce our company and/or offering to leaders of the industry," says Retano. "Our entire business model is built on having a complete, single integrated, turnkey solution that can be customized to meet the needs of our partners. This conference offers us an excellent opportunity to demonstrate what we can do."
Pharmafusion LLC, a privately held company located in East Norriton, Pennsylvania, is a one-stop-shop for pharmaceutical and biotech companies searching for comprehensive data analytics for a wide range of key business performance indicators. Supported by "in-the-trenches" experience on the corporate side of the industry, Pharmafusion provides client partners in marketing, finance, trade, managed-care, sales, clinical, business development, and regulatory with the information required to aid in successful commercialization efforts. The company's primary offering, Pharmafusion360°, goes beyond the breadth of what others in the industry provide, and does so with a quality of functionality and service that is unparalleled. Pharmafusion's current client base represents more than $25 billion in sales.
To learn more about Pharmafusion and its flagship offering, Pharmafusion360°, please visit pharmafusion360.com or email Jonathan Retano at firstname.lastname@example.org.